• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Five Force Summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by End-user o Market segments o Comparison by End-user o Pharmaceutical and biotechnology companies - Market size and forecast 2020-2025 o CROs - Market size and forecast 2020-2025 o Others - Market size and forecast 2020-2025 o Market opportunity by End-user • Customer Landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity by geography o Volume driver o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption o Competitive scenario • Vendor Analysis o Vendors covered o Market positioning of vendors o ArisGlobal LLC o BioClinica Inc. o Bio-Optronics Inc. o Dassault Systemes SE o DATATRAK International Inc. o International Business Machines Corp. o Medpace Holdings Inc. o Oracle Corp. o Parexel International Corp. o Veeva Systems Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2020 - 2025 ($ million) • 13: Global market: Year-over-year growth 2020 - 2025 (%) • 14: Five forces analysis 2020 & 2025 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2020 • 21: End user - Market share 2020-2025 (%) • 22: Comparison by End user • 23: Pharmaceutical and biotechnology companies - Market size and forecast 2020-2025 ($ million) • 24: Pharmaceutical and biotechnology companies - Year-over-year growth 2020-2025 (%) • 25: CROs - Market size and forecast 2020-2025 ($ million) • 26: CROs - Year-over-year growth 2020-2025 (%) • 27: Others - Market size and forecast 2020-2025 ($ million) • 28: Others - Year-over-year growth 2020-2025 (%) • 29: Market opportunity by End user • 30: Customer landscape • 31: Market share by geography 2020-2025 (%) • 32: Geographic comparison • 33: North America - Market size and forecast 2020-2025 ($ million) • 34: North America - Year-over-year growth 2020-2025 (%) • 35: Europe - Market size and forecast 2020-2025 ($ million) • 36: Europe - Year-over-year growth 2020-2025 (%) • 37: Asia - Market size and forecast 2020-2025 ($ million) • 38: Asia - Year-over-year growth 2020-2025 (%) • 39: ROW - Market size and forecast 2020-2025 ($ million) • 40: ROW - Year-over-year growth 2020-2025 (%) • 41: Key leading countries • 42: Market opportunity by geography ($ million) • 43: Impact of drivers and challenges • 44: Vendor landscape • 45: Landscape disruption • 46: Industry risks • 47: Vendors covered • 48: Market positioning of vendors • 49: ArisGlobal LLC - Overview • 50: ArisGlobal LLC - Product and service • 51: ArisGlobal LLC - Key offerings • 52: ArisGlobal LLC - Key customers • 53: ArisGlobal LLC - Segment focus • 54: BioClinica Inc. - Overview • 55: BioClinica Inc. - Product and service • 56: BioClinica Inc. - Key offerings • 57: BioClinica Inc. - Key customers • 58: BioClinica Inc. - Segment focus • 59: Bio-Optronics Inc. - Overview • 60: Bio-Optronics Inc. - Product and service • 61: Bio-Optronics Inc. - Key offerings • 62: Bio-Optronics Inc. - Key customers • 63: Bio-Optronics Inc. - Segment focus • 64: Dassault Systemes SE - Overview • 65: Dassault Systemes SE - Business segments • 66: Dassault Systemes SE - Key offerings • 67: Dassault Systemes SE - Key customers • 68: Dassault Systemes SE - Segment focus • 69: DATATRAK International Inc. - Overview • 70: DATATRAK International Inc. - Business segments • 71: DATATRAK International Inc. - Key offerings • 72: DATATRAK International Inc. - Key customers • 73: DATATRAK International Inc. - Segment focus • 74: International Business Machines Corp. - Overview • 75: International Business Machines Corp. - Business segments • 76: International Business Machines Corp. - Key offerings • 77: International Business Machines Corp. - Key customers • 78: International Business Machines Corp. - Segment focus • 79: Medpace Holdings Inc. - Overview • 80: Medpace Holdings Inc. - Business segments • 81: Medpace Holdings Inc. - Key offerings • 82: Medpace Holdings Inc. - Key customers • 83: Medpace Holdings Inc. - Segment focus • 84: Oracle Corp. - Overview • 85: Oracle Corp. - Business segments • 86: Oracle Corp. - Key offerings • 87: Oracle Corp. - Key customers • 88: Oracle Corp. - Segment focus • 89: Parexel International Corp. - Overview • 90: Parexel International Corp. - Product and service • 91: Parexel International Corp. - Key offerings • 92: Parexel International Corp. - Key customers • 93: Parexel International Corp. - Segment focus • 94: Veeva Systems Inc. - Overview • 95: Veeva Systems Inc. - Business segments • 96: Veeva Systems Inc. - Key offerings • 97: Veeva Systems Inc. - Key customers • 98: Veeva Systems Inc. - Segment focus • 99: Currency conversion rates for US$ • 100: Research Methodology • 101: Validation techniques employed for market sizing • 102: Information sources • 103: List of abbreviations

ArisGlobal LLC, BioClinica Inc., Bio-Optronics Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., Veeva Systems Inc.